1. Acute improvement of pulmonary artery pressure by non-invasive positive pressure ventilation in the patients with hypercapnic respiratory failure
- Author
-
Dursunoğlu, Neşe, Dursunoğlu, Dursun, Moray, Aylin, and Gür, Şükrü
- Subjects
Male ,heart failure ,Respiratory failure ,Pulmonary Artery ,physical examination ,Kulak, Burun, Boğaz ,Solunum Sistemi ,assisted ventilation ,Hypercapnia ,Positive-Pressure Respiration ,Pulmonary Disease, Chronic Obstructive ,Non-invasive positive pressure ventilation ,Female ,Humans ,Hypercapnia/etiology/*therapy ,Middle Aged ,Positive-Pressure Respiration/*methods ,Pulmonary Artery/physiopathology ,Pulmonary Disease, Chronic Obstructive/complications/*therapy ,Pulmonary Wedge Pressure/*physiology ,Respiratory Function Tests ,Respiratory Insufficiency/etiology/*therapy ,Treatment Outcome ,respiratory distress ,carbon dioxide tension ,controlled study ,human ,Pulmonary Wedge Pressure ,clinical article ,hypoxemia ,Chronic obstructive pulmonary disease ,adult ,article ,arterial pH ,lung artery pressure ,Doppler echocardiography ,breathing rate ,Pulmonary arterial pressure ,female ,Echocardiography ,non invasive positive pressure ventilation ,blood gas ,disease severity ,respiratory acidosis ,Respiratory Insufficiency ,chronic obstructive lung disease - Abstract
It is very important to decrease pulmonary artery pressure (PAP) in patients with chronic obstructive pulmonary disease (COPD) in order to prevent progression to right heart failure. We showed an acute improvement of PAP by non-invasive positive pressure ventilation (NPPV) treatment in patients with hypercapnic respiratory failure. In 26 patients with COPD (18 males and 8 females), physical examination, Doppler echocardiographic evaluation and arterial blood gases analysis were performed on admission and at discharge. PAP was measured by Doppler echocardiography. NPPV was used when 2 of the following were present without contraindications: 1. Respiratory distress with moderate to severe dyspnea, 2. Arterial pH less than 7.35 with PaCO2 above 45 mmHg, 3. Respiratory rate of 25/minute or greater. Mean age of the patients was 62.6 ± 10.8 year, and mean usage of the NPPV was 12.6 ± 5.5 day. Mean and systolic PAPs of the patients (43.8 ± 16.9 mmHg and 66.7 ± 23.3 mmHg) were significantly decreased with NPPV treatment (26.6 ± 8.4 mmHg, p< 0.0001 and 41.8 ± 14.6 mmHg, p< 0.0001). Also, each parameter of the arterial blood gases was improved significantly with NPPV usage. An echocardiographic assessment in the COPD patients having NPPV treatment due to acute respiratory failure, might be a useful and easy method to show an improvement of PAP as a supportive measure in the management of those patients, in addition to beneficial effects of that treatment on respiratory acidosis, hypercapnia and hypoxemia.
- Published
- 2010